Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of MRTX849
MRTX849
2326521-71-3
|
604.117
|
5.78
MRTX849 is a covalent inhibitor of K-RasG12C (IC50 = 0.19 nM) , a mutant form of K-Ras that accumulates in cancer cells. Indicated for the treatment of locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer in patients who have received at least one prior systemic therapy.
MRTX849 | adagrasib
MRTX849 is a covalent inhibitor of K-RasG12C (IC50 = 0.19 nM) , a mutant form of K-Ras that accumulates in cancer cells. Indicated for the treatment of locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer in patients who have received at least one prior systemic therapy.
MRTX849 | adagrasib
$41/5 mg
(EBC)
1
We provide 0 compound for MRTX849